Clinical Trials
5 trialsNCT00464646 2021-10-25
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 2 Completed
NCT01123473 2016-10-12
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00755976 2014-12-31
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
Cancer Trials Ireland
Phase 2 Completed
NCT01710592 2013-01-10
ELECT
Cancer Trials Ireland
Phase 2 Completed
NCT00378313 2008-11-26
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
NSABP Foundation Inc
Phase 2 Completed